CENTESSA PHARMACEUTICALS-ADR Share Price Today: Live Updates & Key Insights
CENTESSA PHARMACEUTICALS-ADR share price today is $26.6269, up -4.52%. The stock opened at $28.335 against the previous close of $28.34, with an intraday high of $28.5629 and low of $26.76.
CENTESSA PHARMACEUTICALS-ADR Share Price Chart
CENTESSA PHARMACEUTICALS-ADR
CENTESSA PHARMACEUTICALS-ADR Share Price Performance
CENTESSA PHARMACEUTICALS-ADR Institutional Holdings
CENTESSA PHARMACEUTICALS-ADR Market Status
CENTESSA PHARMACEUTICALS-ADR Fundamentals
Market Cap 3952.81 M
PB Ratio 13.2638
PE Ratio 0.0
Enterprise Value 3872.05 M
Total Assets 576.80 M
Volume 573489
CENTESSA PHARMACEUTICALS-ADR Company Financials
About CENTESSA PHARMACEUTICALS-ADR & investment objective
Company Information Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.
Organisation Biotechnology
Employees 114
Industry Biotechnology
CEO Dr. Mario Alberto Accardi Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
CENTESSA PHARMACEUTICALS-ADR FAQs
What is the share price of CENTESSA PHARMACEUTICALS-ADR today?
The current share price of CENTESSA PHARMACEUTICALS-ADR is $26.6269.
Can I buy CENTESSA PHARMACEUTICALS-ADR shares in India?
Yes, Indian investors can buy CENTESSA PHARMACEUTICALS-ADR shares by opening an international trading and demat account with Motilal Oswal.
How to buy CENTESSA PHARMACEUTICALS-ADR shares in India?
You can easily invest in CENTESSA PHARMACEUTICALS-ADR shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy CENTESSA PHARMACEUTICALS-ADR shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of CENTESSA PHARMACEUTICALS-ADR.
Can I buy fractional shares of CENTESSA PHARMACEUTICALS-ADR?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of CENTESSA PHARMACEUTICALS-ADR?
CENTESSA PHARMACEUTICALS-ADR has a market cap of $3952.81 M.
In which sector does CENTESSA PHARMACEUTICALS-ADR belong?
CENTESSA PHARMACEUTICALS-ADR operates in the Biotechnology sector.
What documents are required to invest in CENTESSA PHARMACEUTICALS-ADR stocks?
To invest, you typically need:
What is the PE and PB ratio of CENTESSA PHARMACEUTICALS-ADR?
The PE ratio of CENTESSA PHARMACEUTICALS-ADR is N/A and the PB ratio is 13.26.